[HTML][HTML] Traditional Chinese medicine intervenes ventricular remodeling following acute myocardial infarction: Evidence from 40 random controlled trials with 3,659 …

XX Zhang, B Liang, CL Shao, N Gu - Frontiers in Pharmacology, 2021 - frontiersin.org
Objectives: We intend to conduct a meta-analysis on the systematic evaluation of traditional
Chinese medicine (TCM) in the treatment of ventricular remodeling following acute …

Targeting brain aminopeptidase A: a new strategy for the treatment of hypertension and heart failure

Y Marc, SE Boitard, F Balavoine, M Azizi… - Canadian Journal of …, 2020 - Elsevier
The pathophysiology of heart failure (HF) and hypertension are thought to involve brain
renin-angiotensin system (RAS) hyperactivity. Angiotensin III, a key effector peptide in the …

沙库巴曲缬沙坦对射血分数中间值心力衰竭患者的预后影响

周永越, 徐兆龙 - 临床心血管病杂志, 2021 - lcxxg.whuhzzs.com
目的: 探讨沙库巴曲缬沙坦对射血分数中间值(HFmrEF) 的心力衰竭(心衰) 患者的预后影响.
方法: 随机选取2018 年1 月—2020 年1 月住院的200 例HFmrEF 患者, 分成对照组和实验组各 …

Rationale and design of a multi‐center, prospective randomized controlled trial on the effects of sacubitril–valsartan versus enalapril on left ventricular remodeling in …

K Diao, D Wang, Z Chen, X Wu, M Ma, Y Zhu… - Clinical …, 2021 - Wiley Online Library
Background Angiotensin receptor neprilysin inhibitor (ARNI) sacubitril‐valsartan has been
recommended as one of the first‐line therapies in heart failure with reduced ejection fraction …

[HTML][HTML] The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic …

J Gao, X Zhang, M Xu, S Deng, X Chen - Frontiers in Pharmacology, 2023 - frontiersin.org
Purpose: To systematically assess the efficacy and safety of sacubitril/valsartan (SV) by
comparison with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor …

A comparative study between angiotensin receptor neprilysin inhibitor (thiorphan/irbesartan) with each of nitrate and carvedilol in a rat model of myocardial ischemic …

T Mohammed Abdulsalam, AH Hasanin… - Fundamental & …, 2023 - Wiley Online Library
The combined angiotensin receptor neprilysin inhibitor is a promising cardioprotective
pharmacological agent. This study investigated the beneficial effects of thiorphan …

Angiotensin receptor–neprilysin inhibitor (thiorphan/irbesartan) improved cardiac function in a rat model of myocardial ischemic reperfusion injury

T Mohammed Abdulsalam, AH Hasanin… - Fundamental & …, 2023 - Wiley Online Library
Mitochondria‐mediated apoptosis plays a critical role in myocardial ischemia reperfusion
(IR) injury and causes a negative impact on cardiac efficiency and function. The combined …

Effects of sacubitril/valsartan on clinical symptoms, echocardiographic parameters, and outcomes in HFrEF and HFmrEF patients with coronary heart disease and …

DM Raphael, Z Liu, Z Jin, X Cui, D Han… - Current Medical …, 2021 - Taylor & Francis
Objective To compare the effects of Angiotensin Receptor-Neprilysin inhibitor (ARNI) on the
clinical symptoms, echocardiographic parameters, and outcomes (cardiovascular death and …

Effect of sacubitril/valsartan on the prognosis of patients with heart failure with midrange ejection fraction

Z Yongyue, XU Zhaolong - J Clin Cardiol, 2021 - lcmwen.whuhzzs.com
Objective: To investigate the effect of prognosis of sacubitril/valsartan in the patients with
heart failure with midrange ejection fraction (HFmrEF). Methods: A total of 200 HFmrEF …

[引用][C] 沙库巴曲/缬沙坦治疗慢性心力衰竭的效果及对左心重构与超敏肌钙蛋白T 水平的影响

郑冠群, 盛晓东 - 中国循证心血管医学杂志, 2021